CPR Investments Inc.
- SEC CIK
- 0001775053
- Latest filing
- Jul 14, 2026
The latest 13F from CPR Investments Inc. covers Q2 2026 (filed Jul 14, 2026): 55 long positions worth $129.9M. The top 10 holdings make up 76.0% of the portfolio, and the largest is Invesco Exch Traded FD Tr II at 25.3%. Livermore has 19 filings on Form 13F from this institution, going back to Q4 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 22
- Est. +$11.2M
- Added
- 12
- Est. +$12.1M
- Reduced
- 20
- Est. −$29.4M
- Sold out
- 18
- Est. −$24.4M
Top 5 holdings
Share of this quarter's portfolio value
- Invesco Exch Traded FD Tr II46138G88825.3%$32.9M
- Investment Managers Ser Tr I46092D73112.7%$16.5M
- Invesco QQQ Trust Series I46090E1036.0%$7.81M
- iShares Tr4642877216.0%$7.80M
- IAUiShares Gold Trust
Share of portfolio
Top 5 holdings and the other 50 positions, by share of portfolio value
- Invesco Exch Traded FD Tr II25.3%
- Investment Managers Ser Tr I12.7%
- Invesco QQQ Trust Series I6.0%
- iShares Tr6.0%
- IAU5.8%
- Other 50 positions44.2%
Biggest buys
New and added positions, by estimated amount bought
- iShares Tr464287457+$3.05MAdded
- Vanguard S&P 500 ETF922908363+$2.06MAdded
- iShares Tr464287721+$1.50MAdded
- Invesco QQQ Trust Series I46090E103+$1.33MAdded
- Direxion Shs ETF Tr25459W102+$1.29MNew
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- iShares Tr464287721+2.98 pp3.0% → 6.0%
- iShares Tr464287457+2.66 pp2.1% → 4.7%
- Invesco QQQ Trust Series I46090E103+2.62 pp3.4% → 6.0%
- Vanguard S&P 500 ETF922908363+2.26 pp2.1% → 4.3%
- Direxion Shs ETF Tr25459W102+0.99 pp0.0% → 1.0%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- GLDSPDR Gold Trust
- ProShares Tr74349Y753−$7.30MSold out
- Invesco Exch Traded FD Tr II46138G888−$6.92MReduced
- iShares Tr464287432−$6.13MSold out
- Investment Managers Ser Tr I46092D731−$4.02MReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- GLDSPDR Gold Trust
- ProShares Tr74349Y753−4.87 pp4.9% → 0.0%
- iShares Tr464287432−4.09 pp4.1% → 0.0%
- State Street SPDR Bloomberg 1-3 Month T-Bill ETF78468R663−2.45 pp3.8% → 1.4%
- iShares Tr464287440−2.24 pp2.2% → 0.0%
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $129.9M
- −$20.0M (−13.3%) vs. prior quarter
- Positions
- 55
- +4 vs. prior quarter
- Top 10 concentration
- 76.0%
- Top 10 as share of value
- Turnover
- 16.7%
- Q2 2026, one quarter
- Average holding period
- 8.2 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.
13F filings by quarter
19 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $149.9M (Q1 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 14, 2026 | 55 | $129.9M | Invesco Exch Traded FD Tr IIInvestment Managers Ser Tr IInvesco QQQ Trust Series I | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 16, 2026 | 51 | $149.9M | Invesco Exch Traded FD Tr IIInvestment Managers Ser Tr IGLD | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 14, 2026 | 47 | $149.0M | Invesco Exch Traded FD Tr IIInvesco QQQ Trust Series IiShares Tr | vs. Q3 2025 | SEC |
| Q3 2025 | Oct 14, 2025 | 51 | $145.3M | Invesco Exch Traded FD Tr IIInvesco QQQ Trust Series IiShares Tr | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 22, 2025 | 45 | $128.8M | Invesco Exch Traded FD Tr IIInvesco QQQ Trust Series IiShares Tr | vs. Q1 2025 | SEC |
| Q1 2025 | Apr 10, 2025 | 37 | $112.7M | Invesco Exch Traded FD Tr IIProShares TrGLD | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 14, 2025 | 35 | $110.8M | Invesco Exch Traded FD Tr IIGLDProShares Tr | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 16, 2024 | 37 | $105.9M | Invesco Exch Traded FD Tr IIGLDState Street SPDR Bloomberg 1-3 Month T-Bill ETF | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 19, 2024 | 42 | $120.9M | Invesco Exch Traded FD Tr IIDirexion Shares ETF TrustGLD | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 19, 2024 | 48 | $131.4M | ProShares TrProShares TrGLD | vs. Q4 2023 | SEC |
| Q4 2023 | Jan 23, 2024 | 36 | $103.2M | ProShares TrGLDState Street SPDR Bloomberg 1-3 Month T-Bill ETF | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 9, 2023 | 35 | $93.1M | ProShares TrGLDState Street SPDR Bloomberg 1-3 Month T-Bill ETF | vs. Q2 2023 | SEC |
| Q2 2023 | Jul 21, 2023 | 38 | $104.1M | ProShares TrGLDState Street SPDR Bloomberg 1-3 Month T-Bill ETF | vs. Q1 2023 | SEC |
| Q1 2023 | May 8, 2023 | 36 | $104.0M | ProShares TrGLDState Street SPDR Bloomberg 1-3 Month T-Bill ETF | vs. Q4 2022 | SEC |
| Q4 2022 | Jan 23, 2023 | 37 | $100.7M | ProShares TrState Street SPDR Bloomberg 1-3 Month T-Bill ETFProShares Tr | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 32 | $77.8M | ProShares TrState Street SPDR Bloomberg 1-3 Month T-Bill ETFInvesco Actvely MNGD Etc FD | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 11, 2022 | 44 | $66.6M | State Street Health Care Select Sector SPDR ETFGlobal X Lithium & Battery Tech ETFState Street SPDR Bloomberg 1-3 Month T-Bill ETF | vs. Q1 2022 | SEC |
| Q1 2022 | May 6, 2022 | 80 | $120.8M | ProShares TrGlobal X Lithium & Battery Tech ETFiShares U.S. Healthcare Providers ETF | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 11, 2022 | 71 | $139.5M | ProShares TrProShares TrProShares Tr | – | SEC |